載入中
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
前收盤價
US$1.27
+US$0.05 · +4.10%
盤中時間採用ET。市場資料可能有所延遲。
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
日內區間
目前US$1.27
52週區間
目前US$1.27
盤中時間採用ET。市場資料可能有所延遲。
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
日內區間
目前US$1.27
52週區間
目前US$1.27
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | — | — | 6529.7萬 USD | 4881.6萬 USD | 4069.7萬 USD |
| 銷貨成本 | — | 36.8萬 USD | — | — | — |
| 毛利 | — | −36.8萬 USD | 6529.7萬 USD | 4881.6萬 USD | 4069.7萬 USD |
| 研究與開發 | 12.2萬 USD | 392.3萬 USD | 1656.1萬 USD | 5245萬 USD | 8564.1萬 USD |
| 銷售、一般及管理費用 | 1214.7萬 USD | 1353.2萬 USD | 2329.5萬 USD | 3313萬 USD | 3054萬 USD |
| 營業費用 | 1226.9萬 USD | 1708.7萬 USD | 5075.5萬 USD | 8558萬 USD | 1.16億 USD |
| 利息收入 | 26.7萬 USD | 102.6萬 USD | 327.7萬 USD | 334.5萬 USD | 28.4萬 USD |
| 折舊和攤銷 | — | 36.8萬 USD | 38.3萬 USD | 38.6萬 USD | 32.6萬 USD |
| 營業利益 | −1226.9萬 USD | −1745.5萬 USD | 1454.2萬 USD | −3676.4萬 USD | −7548.4萬 USD |
| 淨利 | −7115萬 USD | −1594.5萬 USD | 1777.8萬 USD | −3183.8萬 USD | −5445.4萬 USD |
公司資料更新於 2026年10月11日。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2023年11月16日 | US$1.75Special | 2023年11月17日 | 2023年12月6日 |
除息 2023年11月16日
US$1.75
Special
2023年11月17日登記 · 支付日 2023年12月6日
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
